Griffith Laboratories & Micocin

Griffith Laboratories & Micocin

February 07, 2011 10:49 ET

Revolutionary New Food Ingredient, Micocin®, Fights Listeria

Griffith Laboratories Receives Health Canada Approval

TORONTO, ONTARIO--(Marketwire - Feb. 7, 2011) - A revolutionary anti-Listeria product, Micocin(R), has been approved for sale by Health Canada announced global food leader Griffith Laboratories. Designed to recognize, target and inhibit the growth of bacteria, Micocin is a targeted solution that can reduce the risk of serious Listeria outbreak and food product recall by controlling the growth of Listeria in packaged meat products.

Micocin was developed from a strain of naturally-occurring bacteria, Carnobacteria maltaromaticum, which produces a bacteriocin that is especially effective against Listeria monocytogenes. This food technology has been developed into a variety of products by CanBiocin, a company formed by a team from the University of Alberta in partnership with Griffith Laboratories.

"With new Canadian legislation expected to be introduced on April 1st, 2011 designed to reduce the risk of Listeria in Ready to Eat Foods in response to the Weatherill Report, we are excited to bring this groundbreaking ingredient to the marketplace," said David Smith, Senior Vice President of New Technology at Griffith Laboratories. "We believe that Micocin can play a key role in helping our customers meet the challenge of the new rules."

Unlike any other Listeria preventative, Micocin is derived from a live, naturally occurring organism. The superfine powder is diluted in water and then precisely deposited onto foods during the packaging process, creating an environment in which Listeria cannot thrive – creating the most powerful and effective protection for foods and ultimately, consumers, in the industry.

The Micocin bacteria culture is already being used in consumer food products and it has no effect on the flavour, texture or appearance of the products to which it is introduced, so consumers can be protected without the addition of extra chemicals or technical-sounding ingredients being added to the food label.

The approval of Micocin is one example of how Health Canada has responded to the Weatherill Report's recommendation that additives that reduce the growth of pathogens like Listeria and have proven health and food safety benefits be evaluated more quickly. The Report of the Independent Investigator into the 2008 Listeria Outbreak. the Weatherill Report, was the result of a serious listeriosis outbreak in the summer of 2008 in ready-to-eat meat that caused the death of 23 Canadians and proposed 57 recommendations to help prevent future outbreaks.

The Canadian approval means that customers in Canada as well as the U.S. can begin using Micocin to help control Listeria in finished products. Micocin has been granted GRAS status, including GRAS Notice 305, in the U.S. and has been approved by the U.S. Department of Agriculture for addition to processed meat products. The product is also approved in Mexico, Costa Rica and Colombia.

About Griffith Laboratories:

Griffith Laboratories is a privately-held, family-owned manufacturer of ingredient blends, ranging from seasonings to coating systems in dry and liquid formats, all providing a wide range of taste and texture food solutions for customers throughout the food industry. Since its inception in 1919, the Alsip, Illinois-based Griffith Laboratories has grown to establish a solid global presence with worldwide manufacturing facilities able to provide coverage to all major markets. Strategically located regional offices, development laboratories and culinary solution centers extend Griffith's reach to its customers throughout the world.

Griffith Laboratories is focused on making the world's food better by creating customized and differentiating ingredient blends for customers. Competitive markets, demanding consumers and global markets present new challenges – and new opportunities – for today's food industry. In addition to its commitment to providing unique ingredient blends, Griffith Laboratories is dedicated to providing the range of skills, experience, and innovations its customers need to succeed in this evolving environment. Acting as exclusive sales source for Micocin is just one example. 

About CanBiocin Inc.

CanBiocin Inc. is a privately-held R & D company that specializes in the development of innovative and socially beneficial lactic acid bacteria-based products. CanBiocin was formed in 1998 as a University of Alberta spin-off company to commercialize novel technologies developed from research conducted by professors Michael Stiles, Lynn McMullen and John Vederas. The technologies are based on the application of lactic acid bacteria (LAB) for food safety and to enhance animal and human health. The team partnered with Griffith Laboratories for their extensive expertise in the meat industry.

For more information on Micocin, please visit www.micocin.com or contact your Griffith Laboratories sales representative.

Contact Information

  • For more information or to arrange an interview,
    please contact:
    Diana Degan & Associates
    Diana Degan
    416-871-5420 / 519-829-3804
    dianadeganassociates@rogers.com